Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vericel Corp (NASDAQ:VCEL)

3.40
Delayed Data
As of Jul 21
 +0.05 / +1.49%
Today’s Change
2.00
Today|||52-Week Range
4.55
+13.33%
Year-to-Date
No recent news for Vericel Corp.

Today’s Trading

Previous close3.35
Today’s open3.35
Day’s range3.30 - 3.50
Volume763,344
Average volume (3 months)293,064
Market cap$109.8M
Dividend yield--
Data as of 3:59pm ET, 07/21/2017

Growth & Valuation

Earnings growth (last year)-21.65%
Earnings growth (this year)+32.42%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+6.28%
P/E ratioNM
Price/Sales1.27
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CPIXCumberland Pharmaceu...+0.13+1.89%
MEIPMEI Pharma Inc-0.05-1.63%
--EcoGreen Internation...+0.00+1.91%
ORMPOramed Pharmaceutica...-0.02-0.23%
Data as of 4:00pm ET, 07/21/2017

Financials

Next reporting dateAugust 8, 2017
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$54.4M
Annual profit (last year)-$19.6M
Net profit margin-35.98%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Dominick C. Colangelo
Chief Operating Officer
Daniel R. Orlando
Corporate headquarters
Cambridge, Massachusetts

Forecasts